Actively Recruiting
68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study
Led by Centre de recherche du Centre hospitalier universitaire de Sherbrooke · Updated on 2024-02-07
1000
Participants Needed
1
Research Sites
262 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This project aims to monitor the innocuity/safety profile of cyclotron-produced \[68Ga\]-PSMA-617 PET imaging in PSMA-expressing cancers. It is a single-site, pragmatic, non-randomized and open-label study, with no control group. Although prostate cancers constitute the usual recommended population for this PET modality, recent evidences suggest that most solid tumors express substantial amount of PSMA in their neovasculature. As such, all cancers (excluding non-solid cancers) will be eligible for \[68Ga\]-PSMA-617 PET imaging in this trial, for as long as their tumors express PSMA. This study also aims to instigate the use of \[68Ga\]-PSMA-617 in the routine standard-of-care for detection and follow-up of eligible cancers. FInally, this project seeks to gather information about the impact on patient management this novel PET modality will have over the current standard-of-care.
CONDITIONS
Official Title
68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical requisition for a 68Ga-PSMA-617 PET/CT signed by a referring doctor
- Patients with suspected, proven or prior tumor expressing PSMA
- Patient provides informed consent
You will not qualify if you...
- Patient refuses to participate
- Prior severe anaphylactic reaction to 68Ga-PSMA-617
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHUS
Sherbrooke, Quebec, Canada, J1H5N4
Actively Recruiting
Research Team
S
Stéphanie Dubreuil
CONTACT
M
Michel Paquette, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here